Patent Application
App. No. 12/099,465
Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same
Loading inventors, assignments & file history…
Abstract
The current invention relates to genetically engineered mice, cells derived from those mice, and polynucleotides and polypeptides corresponding to genes affected by the engineered mutation. The invention also relates to antibodies raised in a mouse of the invention. The invention further provides methods for using the mice, cells, polynucleotides, polypeptides and antibodies of the invention.
Claims (2)
1 - 4 . (canceled)
7 . A transgenic mouse whose genome comprises a disruption of a gene comprising SEQ ID NO: 11 and wherein said disruption results in enhanced learning and memory in (−/−) mice.
Assignments (2)
RELEASE OF SECURITY INTEREST
Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST
Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →